Ranking Vaccines: A Prioritization Framework: Phase I: Demonstration of Concept and a Software Blueprint | Agenda Bookshop Skip to content
LAST CHANCE! Order items marked '10-20 working days' TODAY to get them in time for Christmas!
LAST CHANCE! Order items marked '10-20 working days' TODAY to get them in time for Christmas!
A01=Board on Global Health
A01=Board on Population Health and Public Health Practice
A01=Committee on Identifying and Prioritizing New Preventive Vaccines for Development
A01=Institute of Medicine
Age Group_Uncategorized
Age Group_Uncategorized
Author_Board on Global Health
Author_Board on Population Health and Public Health Practice
Author_Committee on Identifying and Prioritizing New Preventive Vaccines for Development
Author_Institute of Medicine
automatic-update
B01=Charles Phelps
B01=Dennis Fryback
B01=Kinpritma Sangha
B01=Lonnie King
B01=Rose Marie Martinez
B01=Tracy Lieu
Category1=Non-Fiction
Category=MJCM
Category=MMG
COP=United States
Delivery_Delivery within 10-20 working days
Language_English
PA=Available
Price_€50 to €100
PS=Active
softlaunch

Ranking Vaccines: A Prioritization Framework: Phase I: Demonstration of Concept and a Software Blueprint

As a number of diseases emerge or reemerge thus stimulating new vaccine development opportunities to help prevent those diseases, it can be especially difficult for decision makers to know where to invest their limited resources. Therefore, it is increasingly important for decision makers to have the tools that can assist and inform their vaccine prioritization efforts.

In this first phase report, the IOM offers a framework and proof of concept to account for various factors influencing vaccine prioritization-demographic, economic, health, scientific, business, programmatic, social, policy factors and public concerns. Ranking Vaccines: A Prioritization Framework describes a decision-support model and the blueprint of a software-called Strategic Multi-Attribute Ranking Tool for Vaccines or SMART Vaccines. SMART Vaccines should be of help to decision makers. SMART Vaccines Beta is not available for public use, but SMART Vaccines 1.0 is expected to be released at the end of the second phase of this study, when it will be fully operational and capable of guiding discussions about prioritizing the development and introduction of new vaccines.

Table of Contents
  • Front Matter
  • Summary
  • 1 Introduction: From Smallpox to SMART Vaccines
  • 2 Modeling Strategy: From Single Attribute to Multiple Attributes
  • 3 Data Evaluation and Software Development
  • 4 Observations and Looking Forward
  • References
  • Appendix A: Mathematical Functions
  • Appendix B: Candidate Disease Profiles and Data
  • Appendix C: Stakeholder Speakers
  • Appendix D: Biographical Information
See more
Current price €59.84
Original price €62.99
Save 5%
A01=Board on Global HealthA01=Board on Population Health and Public Health PracticeA01=Committee on Identifying and Prioritizing New Preventive Vaccines for DevelopmentA01=Institute of MedicineAge Group_UncategorizedAuthor_Board on Global HealthAuthor_Board on Population Health and Public Health PracticeAuthor_Committee on Identifying and Prioritizing New Preventive Vaccines for DevelopmentAuthor_Institute of Medicineautomatic-updateB01=Charles PhelpsB01=Dennis FrybackB01=Kinpritma SanghaB01=Lonnie KingB01=Rose Marie MartinezB01=Tracy LieuCategory1=Non-FictionCategory=MJCMCategory=MMGCOP=United StatesDelivery_Delivery within 10-20 working daysLanguage_EnglishPA=AvailablePrice_€50 to €100PS=Activesoftlaunch
Delivery/Collection within 10-20 working days
Product Details
  • Dimensions: 178 x 254mm
  • Publication Date: 11 Oct 2012
  • Publisher: National Academies Press
  • Publication City/Country: United States
  • Language: English
  • ISBN13: 9780309255257
We use cookies to ensure that we give you the best experience on our website. If you continue we'll assume that you are understand this. Learn more
Accept